IN2013MU01239A - - Google Patents

Download PDF

Info

Publication number
IN2013MU01239A
IN2013MU01239A IN1239MU2013A IN2013MU01239A IN 2013MU01239 A IN2013MU01239 A IN 2013MU01239A IN 1239MU2013 A IN1239MU2013 A IN 1239MU2013A IN 2013MU01239 A IN2013MU01239 A IN 2013MU01239A
Authority
IN
India
Prior art keywords
methylphenidate
salts
relates
present
modified release
Prior art date
Application number
Inventor
Girish Kumar Jain
Rahul Sudhakar Dabre
Jitendrakumar Chordiya
Inderjeetsingh Huda
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to IN1239MU2013 priority Critical patent/IN2013MU01239A/en
Publication of IN2013MU01239A publication Critical patent/IN2013MU01239A/en

Links

Abstract

The present invention relates to a process for preparing modified release pharmaceutical compositions of methylphenidate or salts thereof. In particular, the present invention relates to a modified release pharmaceutical composition comprising plurality of components exhibiting both immediate and extended release of methylphenidate or salts thereof. The composition may provide extended and specific release of methylphenidate or salts thereof to achieve therapeutically effective plasma concentration over a period of 12 hours to treat attention deficit disorders when administered to a patient in need thereof.
IN1239MU2013 2013-03-29 2013-03-29 IN2013MU01239A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN1239MU2013 IN2013MU01239A (en) 2013-03-29 2013-03-29

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1239MU2013 IN2013MU01239A (en) 2013-03-29 2013-03-29

Publications (1)

Publication Number Publication Date
IN2013MU01239A true IN2013MU01239A (en) 2015-04-17

Family

ID=54395621

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1239MU2013 IN2013MU01239A (en) 2013-03-29 2013-03-29

Country Status (1)

Country Link
IN (1) IN2013MU01239A (en)

Similar Documents

Publication Publication Date Title
PH12019502355A1 (en) Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis b
MX2013011908A (en) Compositions and therapeutic uses of ikk-related kinase epsilon and tankbinding kinase 1 inhibitors.
TN2015000278A1 (en) Autotaxin inhibitors
IN2014DN09434A (en)
BR112015003188A2 (en) COMPOUND, PHARMACEUTICAL COMPOSITION, COMPOUND USE, AND METHOD FOR TREATMENT OF A RORGAMMAT-MEDIATED DISEASE OR CONDITION IN A PATIENT
MX365939B (en) Nuclear transport modulators and uses thereof.
EA201690107A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYLFUMATE FOR INTRODUCTION TO LOW DAILY DOSE
GB201118656D0 (en) New compounds
MX2013012053A (en) Inhibitors of viral replication, their process of preparation and their therapeutical uses.
MX344238B (en) Tetrazole compounds and methods of making and using same.
MX2013011691A (en) Inhibitors of viral replication, their process of preparation and their therapeutical uses.
MX2015004362A (en) Ketamine derivatives.
JO3122B1 (en) Estra-1,3,5(10),16-tetraene-3-carboxamide derivatives, processes for their preparation, pharmaceutical preparations comprising them and their use for preparing medicaments
EA032271B9 (en) Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases
MX367926B (en) Pharmaceutical composition for a sustained release of lanreotide.
MX2015008187A (en) Deuterated alk inhibitors.
MX2015005732A (en) Tricyclic compounds and methods of making and using same.
MX2015005733A (en) Tricyclic compounds for use in the treatment and/or control of obesity.
GB201115977D0 (en) Neurodevelopmental disorders
IN2013MU01239A (en)
IN2013MU01243A (en)
IN2013MU01240A (en)
IN2013MU01241A (en)
IN2013MU01242A (en)
IN2013MU01247A (en)